Vyepti® (eptinezumab) is a quarterly intravenous treatment designed to prevent migraines before they begin. Unlike daily medications or monthly injections, Vyepti is administered only four times per year and targets CGRP, a key migraine signaling molecule. Learn how this innovative therapy works, who may qualify, what side effects to consider, and the insurance steps often required before treatment can begin. This guide reviews the benefits, risks, and practical consideration

Trigeminal neuralgia is one of the most severe pain conditions encountered in medicine. This physician-guided review explains the anatomy of the trigeminal nerve, why pain occurs, and how modern therapies—including targeted topical anticonvulsants and anti-inflammatory agents—can provide relief. Learn how nerve-specific diagnosis improves outcomes and expands treatment beyond traditional medications and surgery.

Migraines and sinus headaches are often confused because they can share facial pain, congestion, and watery eyes—but they are fundamentally different conditions that require different treatments. Migraines are a neurological disorder commonly associated with throbbing head pain, nausea, and sensitivity to light and sound, while true sinus headaches result from inflamed or infected sinus cavities and are typically accompanied by thick nasal discharge, fever, and pain that wors